Cargando…
Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone
BACKGROUND: Giant cell tumour of bone (GCTB) is an expansile osteolytic tumour which contains numerous osteoclast-like giant cells. GCTB frequently recurs and can produce metastatic lesions in the lungs. Bisphosphonates are anti-resorptive drugs which act mainly on osteoclasts. METHOD: In this study...
Autores principales: | Balke, Maurice, Campanacci, Laura, Gebert, Carsten, Picci, Piero, Gibbons, Max, Taylor, Richard, Hogendoorn, Pancras, Kroep, Judith, Wass, John, Athanasou, Nicholas |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940802/ https://www.ncbi.nlm.nih.gov/pubmed/20799989 http://dx.doi.org/10.1186/1471-2407-10-462 |
Ejemplares similares
-
Cell Biology of Giant Cell Tumour of Bone: Crosstalk between m/wt Nucleosome H3.3, Telomeres and Osteoclastogenesis
por: Forsyth, Ramses G., et al.
Publicado: (2021) -
A short-term in vivo model for giant cell tumor of bone
por: Balke, Maurice, et al.
Publicado: (2011) -
Bisphosphonate Treatment of Benign Multifocal and Unifocal Osteolytic Tumours of Bone
por: Gibbons, C. L. M. H., et al.
Publicado: (2003) -
Mutation-driven epigenetic alterations as a defining hallmark of central cartilaginous tumours, giant cell tumour of bone and chondroblastoma
por: Venneker, Sanne, et al.
Publicado: (2019) -
Adjuvant Zoledronic Acid in High‐Risk Giant Cell Tumor of Bone: A Multicenter Randomized Phase II Trial
por: Lipplaa, Astrid, et al.
Publicado: (2019)